Upstream Bio, Inc. Common Stock (NASDAQ: UPB) last traded at $6.97, up 1.75% on the session. The quote above updates while this page is open; the figures below are drawn from Upstream Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Upstream Bio, Inc. Common Stock trades on NASDAQ under the ticker UPB. Its market capitalisation is $381.75 million.
Valuation measures for Upstream Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $381.75M |
|---|---|
| Enterprise value | $312.57M |
| Price / sales | 120.88 |
| Price / book | 1.41 |
| Beta | 1.07 |
Trailing-twelve-month figures tagged in Upstream Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.16M |
|---|---|
| Net income (TTM) | -$156.50M |
| EPS (TTM) | -$2.89 |
| Operating margin | -5382.65% |
| Return on equity | -57.76% |
| Cash | $79.40M |
Range and volume for UPB over the past 52 weeks.
| 52-week high | $33.68 |
|---|---|
| 52-week low | $5.85 |
| Volume | 434.1K |
| Average volume | 603.9K |
| Previous close | $6.85 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.